Journal article
CK5 is more sensitive than CK5/6 in identifying the "basal-like" phenotype of breast carcinoma
American journal of clinical pathology, v 130(5), pp 724-730
01 Nov 2008
PMID: 18854264
Featured in Collection : UN Sustainable Development Goals @ Drexel
Abstract
Multiple immunohistochemical stains, including cytokeratin (CK)5/6, are used in a panel format to identify "basal-like" carcinomas. We set out to determine the sensitivity and specificity of the CK5 antibody (clone XM26) and compared its expression with that of CK5/6 (clone D5/16B4) in a variety of breast carcinoma cases. The study was performed on 3 breast carcinoma tissue microarrays (TMAs). TMA-1 consisted of 59 consecutive breast carcinoma cases. TMA-2 (n = 16) and TMA-3 (n = 11) consisted of basal-like breast carcinomas previously characterized morphologically and immunohistochemically at our institution. Of the 86 total cases, 20 were positive for CK5 and CK5/6, 14 were positive for CK5 only, and 52 were negative for both. The sensitivity of CK5 for identifying basal-like tumors was 97% compared with 59% for CK5/6. Both antibodies had comparable specificity of more than 95%. For positive cases, the percentage and intensity of staining was much higher with CK5 than with CK5/6 (P = .0001).
Metrics
Details
- Title
- CK5 is more sensitive than CK5/6 in identifying the "basal-like" phenotype of breast carcinoma
- Creators
- Rohit Bhargava - Magee-Womens HospitalSushil BeriwalKim McManusDavid J Dabbs
- Publication Details
- American journal of clinical pathology, v 130(5), pp 724-730
- Resource Type
- Journal article
- Language
- English
- Academic Unit
- Radiation Oncology (and Nuclear Medicine)
- Web of Science ID
- WOS:000260188600007
- Scopus ID
- 2-s2.0-55249099328
- Other Identifier
- 991021897389204721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
- Web of Science research areas
- Pathology